Amarantus Bioscience - AMBS - Launching first diagnostic blood test to detect Alzheimer's this year. Partnership currently being finalized. Up-listing to the NASDAQ in 4Q2014.
Currently trading under a dozen pennies.
Read the recent Yahoo news. Company's patented drug, MANF, already has three orphan indications.
Updates from C.E.O. this week.
Twitter: @AmarantusBio .... 10,200 followers.